The acquisition brings to a close a controversial chapter in Noven's history. The company had two product recalls last year and was cited by the FDA for manufacturing problems in 2007. It had to pay Shire $4 million for manufacturing failures. Brandt and his team all got cash bonues for their 2008 performance despite those errors because revenue and net income went up. Noven was also involved in a joint venture with Procter & Gamble to develop a "Viagra for Women" product; that's category that has seen much failure and little success from other companies.